SEATTLE GENETICS INC (39) | Uncategorized (4)
- Joint Commercialization Agreement dated October 19, 2020 between Genmab A/S and Seagen Inc. (f.k.a. Seattle Genetics Inc.) (Filed With SEC on February 12, 2021)
- Amendment No. 1 (Filed With SEC on July 31, 2020)
- Description of Securities of Seattle Genetics, Inc (Filed With SEC on February 6, 2020)
- Joint Commercialization Agreement dated October 20, 2018 between Seattle Genetics, Inc. and Agensys, Inc (Filed With SEC on July 16, 2019)
